Generex Biotechnology Corporation (OTC:GNBT)
Industry: Healthcare

Listed 4 Consecutive Market Days. On List as of 02/15/2012 Through 02/22/2012

Generex Biotechnology Corporation, through its subsidiary, Hema Diagnostic Systems, LLC, focuses on the development, manufacture, and distribution of in-vitro medical diagnostics for infectious diseases in Canada and the United States. The company offers Rapid Diagnostic Tests for human immunodeficiency virusĀ?Ā½ w/p24Ab, tuberculosis-XT, malaria, hepatitis, syphilis, typhoid, dengue, and other infectious diseases. Generex Biotechnology Corporation was founded in 1983 and is based in Miramar, Florida.

Current Quote*
Last: $17.500
Change: -3.500
Book: $Unk
Volume: 5,155

As Of: 11/21 11:11 ET
*Quotes delayed by 20min.

Graphs for GNBT

3 Month Graph

6 Month Graph

1 Year Graph